U.S. Food and Drug Administration

Collage of images including drug vials with syringe, 3D rendering of coronavirus, and closeup of a person being administered a shot

Featured

FDA Takes Action to Address Coronavirus Disease 2019 (COVID-19)

FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

Small Business and Industry Assistance Regulatory Education for Industry Promotion Text

Learn about FDA’s COVID-19 experiences and activities

Insights from three medical product centers: drugs, devices, and biologics

New Era of Smarter Food Safety

A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Jul 23

Coronavirus (COVID-19) Update: July 23, 2021

Jul 20

Coronavirus (COVID-19) Update: July 20, 2021

More Press Announcements

Newsroom Meetings Testimony Speeches

Jul 27

Cahill Cheddar Cheeses Voluntarily Recalled in 44 Whole Foods Market Stores Due to Possible Health Risk

Food & Beverages

Jul 27

Voluntary Recall Notice of McCormick Italian Seasoning Products and Frank’s RedHot Buffalo Ranch Seasoning Due to Possible Salmonella Risk

Food & Beverages

Jul 26

Excalibur Seasoning Company Recalls Seasoning Blend Because of Possible Health Risk

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List

Paragraph Header

Image that depicts a photo of a panel discussion on the left, and a group photo of the Patient Engagement Collaborative participants

FDA Seeks Patient Insight: Call for Applications for the Patient Engagement Collaborative

The FDA is announcing the call for applications for the next cohort of the Patient Engagement Collaborative.

FDA Budget Fiscal Year 2022. Top image of N95 masks. Left image of gloved hand holding cotton swab for testing. Right image of respirator next to hospital bed. Bottom image of latex gloves.

FDA’s Budget: Medical Device Supply Chain and Shortages Prevention Program

Investments outlined in FDA’s FY 2022 budget will provide resources to establish a permanent program for U.S. supply chain resilience for medical devices.

Image that depicts a pregnant woman getting a needle in her arm, and a pregnant woman holding a bottle of pills.

Global Regulators Envision Paradigm Shift Toward Inclusion of Pregnant and Breastfeeding Women in Clinical Research for Medicines and Vaccines

A major paradigm shift is necessary from the systemic exclusion to the inclusion of pregnant and breastfeeding women in clinical studies.

More FDA Voices

Jul 28

Rabies: Developing Monoclonal Antibody Cocktails for the Passive Immunization Component of Post-Exposure Prophylaxis Guidance for Industry

Drugs

Jul 22